Antibody Discovery Market Report 2026

Antibody Discovery Market Overview

• Antibody Discovery market size has reached to $9.78 billion in 2025 • Expected to grow to $15.79 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: Antibody Discovery Market Fueled By Rising Demand For Precision Therapeutics • Market Trend: AI-Powered Platforms Revolutionize Therapeutic Development • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Antibody Discovery Market?

Antibody discovery refers to the process of identifying and developing antibodies, which are proteins produced by the immune system to help defend the body against harmful substances, such as bacteria and viruses. Antibodies, also known as immunoglobulins, play a crucial role in the immune response by recognizing and binding to specific molecules called antigens. The main types of methods in antibody discovery are phage display, hybridoma, and others. Phage display is a molecular biology technique used for the study and selection of peptides or proteins, typically antibodies, that bind with high affinity to a target of interest and is widely employed in antibody discovery to generate and select antibodies with specific binding properties. The antibody types include humanized antibodies, human antibodies, chimeric antibodies, and murine antibodies used by end users in the pharmaceutical and biotechnology industries, research laboratories, and academic laboratories.

What Is The Antibody Discovery Market Growth Forecast?

The antibody discovery market size is expected to see rapid growth in the next few years. It will grow to $15.79 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to growth in personalized medicine demand, adoption of ai and ml in drug discovery, expansion of biologics market, integration of high-throughput screening platforms, rising focus on immunotherapy and targeted therapies. Major trends in the forecast period include high-throughput screening techniques, monoclonal antibody advancements, personalized antibody therapeutics, multi-specific antibody development, synthetic antibody engineering.

Global Antibody Discovery Market Segmentation

1) By Methods: Phage Display, Hybridoma, Other Methods 2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody 3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory Subsegments: 1) By Phage Display: Selection And Screening Techniques, Optimization Methods 2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes 3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

What Is The Driver Of The Antibody Discovery Market?

The growing need for precision therapeutics is expected to propel the growth of the antibody discovery market going forward. Precision therapeutics, also known as personalized therapeutics, refers to the customization of medical treatment plans and interventions to the individual characteristics of each patient. Antibody discovery is used in precision therapeutics, enabling the development of targeted therapies, such as monoclonal antibodies, designed to interact with disease-related molecules or cells specifically and precisely for more effective and personalized treatment. For instance, in March 2024, according to the IQVIA Holdings Inc., a US-based provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries, global spending on cell and gene therapies surged to $5.9 billion in 2023, an increase of 38% from 2022. Therefore, the growing need for precision therapeutics will drive the growth of the antibody discovery industry.

Key Players In The Global Antibody Discovery Market

Major companies operating in the antibody discovery market are Charles River Laboratories, WuXi Biologics, Genmab A/S, Evotec, ChemPartner, Aragen Life Science Pvt. Ltd., GenScript Technology Corporation, Biocytogen, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A., Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio Technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

Global Antibody Discovery Market Trends and Insights

Major companies operating in the antibody discovery market are developing innovative technologies, such as an AI-based computational antibody drug discovery platform, to improve the efficiency and precision of antibody development. An AI-based computational antibody drug discovery platform utilizes artificial intelligence and computational techniques to expedite the identification and optimization of therapeutic antibodies. For instance, in October 2023, SwiftPharma BV, a Belgium-based company developing recombinant proteins from a specialized plant-based system, introduced an AI-driven antibody discovery platform. This innovative tool combines artificial intelligence, big data, machine learning, and phage display techniques to rapidly predict high-specificity and high-affinity antibody-antigen binding. This approach, akin to natural language processing, generates diverse antibody variations, enabling SwiftPharma to create comprehensive antibody libraries efficiently. This advanced system accelerates the discovery of potential antibody drugs with unprecedented speed.

What Are Latest Mergers And Acquisitions In The Antibody Discovery Market?

In July 2024, Pentixapharm, a Germany-based radiopharmaceutical biotech, acquired Glycotope's target discovery unit for an undisclosed amount. This acquisition aligns with Pentixapharm’s strategy to expand its oncology pipeline by transforming preclinical antibodies against multiple cancer targets into radiopharmaceuticals. Along with the preclinical assets, Pentixapharm also gained Glycotope’s laboratories, cell banks, tumor target database, and equipment, further strengthening its Intellectual Property portfolio beyond the CXCR4 receptor. Glycotope, is a Germany-based, is a biotechnology company specializing in developing glyco-optimized antibodies for cancer immunotherapies.

Regional Insights

North America was the largest region in the antibody discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Antibody Discovery Market?

The antibody discovery market includes revenues earned by entities by providing services such as antigen identification, immunization, antibody generation, screening, and characterization. The market value includes the value of related goods sold by the service provider or included within the service offering. The antibody discovery market also includes sales of antibody libraries, phage display kits, antigen proteins, and antibody screening platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Antibody Discovery Market Report 2026?

The antibody discovery market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the antibody discovery industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.